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1. Introduction 
The halogen ion probe technique introduced by 
Stengle and Baldeschwieler [ 1 ] has been utilized in 
the study of metal complexes of several proteins 
[2-81 . Investigations of zinc-containing and zinc- 
activated enzymes with this method are the subject 
of two recent publications [9, lo]. The purpose of 
the present communication is to report on the use 
of 35Cl and 8lBr nuclear magnetic resonance in the 
study of E. coli alkaline phosphatase. 
Alkaline phosphatase isolated from E. coli cells is 
a zinc metalloprotein with a molecular weight of 
about 80,000 [ 1 l-l 31. The zinc content of the 
enzyme is in dispute, but two equivalents of zinc are 
firmly bound to the protein and are necessary for 
activity [ 14-191. Furthermore, the enzyme has been 
reported to bind specifically other transition metal 
ions [ 121 . Zinc binding has been investigated by 
several authors [20,21] , and on the basis of these 
studies different conclusions have been reached 
about the nature of zinc binding to the enzyme. 
E. coli alkaline phosphatase becomes phosphorylated 
by either substrate or phosphate to form a phosphoryl 
enzyme intermediate, in which the phosphate is 
covalently bound to a serine residue [22] . It has been 
shown that apophosphatase is unable to bind phos- 
phate [23], hence the metal ions of the native enzyme 
must play a very important role in the phosphate 
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binding and in the formation of the phosphoryl en- 
zyme. To gain more insight into the mode of action 
of the metal ions in this protein, additional work is 
required employing various independent methods. 
Since the halide ion NMR technique has been shown 
to be valuable for the investigation of zinc - protein 
interactions [9, lo], this method was applied to 
E. coli alkaline phosphatase for the studies presented 
here. 
The findings of the present investigation are that 
the 35Cl nuclear magnetic resonance line width in 
aqueous chloride solutions is slightly broadened upon 
the addition of apophosphatase, while dramatic in- 
creases in line width were observed in the presence of 
some metallophosphatases. Addition of phosphate 
reduces the line broadening caused by Zn2+-alkaline 
phosphatase. The *l Br NMR line width is at pH 7.8 
strongly dependent on the zinc content. At higher 
and lower pH values addition of zinc ions to an 
aqueous bromide solution containing apophosphatase 
produces much smaller’81Br line broadening. 
2. Experimental 
2.1 . Materials 
Purification, enzyme assay and protein concen- 
tration measurements were carried out as previously 
described [21] . The metal-free protein was prepared 
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by treating the metalloprotein with Chelex 100 [2 1 ] . 
The preparation of Co2+ - and Cu2+-alkaline phos- 
phatases from the apoenzyme was performed by 
methods previously described [24,25] . Metal anal- 
yses for Zn and Co were performed by atomic ab- 
sorption spectroscopy; for Cu as described earlier 
[26]. Metal solutions were prepared from spectro- 
graphically pure metal chlorides, and all the other 
chemicals were of analytical grade. Metal-free solu- 
tions were obtained by extraction with dithizone [21], 
and glassware was treated as described by Thiers 
v71. 
2.2. NMR measurements 
The 35Cl magnetic resonance signal was recorded 
with a Varian HA-lOOD-15 NMR spectrometer at a 
magnetic field strength of 23.5 kG. The radio-fre- 
quency field was obtained from a Varian V-43 11 
Fixed Frequency Unit. The probe constructed for 
these measurements was made in essentially the same 
way as the wide-line probes supplied by Varian. The 
modulation field was taken from the “manual oscil- 
lator” and was amplified in order to obtain a con- 
venient signal-to-noise ratio.$The modulation fre- 
quency was 1500 Hz. The field was swept by the 
V-3508 unit (slow sweep), and the spectra were cali- 
brated with the conventional sideband technique. The 
line widths were taken as the signal breadth at half 
intensity of the absorption signal and were repro- 
ducible within + 10% except for a few very broad sig- 
nals. The reported line widths usually are the averages 
of six individual runs. The rate of passage through 
resonance and the amplitude of the r.f. field were 
chosen small enough to give no detectable distortion 
of the signals. It may be seen in fig. 1 that the recorded 
signals are slightly unsymmetrical in the case of broad 
curves. This is due to a baseline drift at the highest 
amplifications caused by thermal fluctuations in the 
probe which lacked provision for temperature stabi- 
lization. Since this drift is very nearly constant it 
could easily be corrected for. The temperature used 
was 3 1 ? 1’. The samples were contained in test 
tubes an inner diameter of 14 mm. 
A Varian V-4200 NMR spectrometer equipped 
with a 12 inch V-3603 magnet was used for the * ‘Br 
measurements at a magnetic field of 13.75 kG and a 
temp. of 29 f 2”. The line width was in this case taken 
as the distance between maximum and minimum slope 
of the absorption signal. The error in the reported line 
widths, which are the arithmetic means of 2-3 spectra, 
is about 10%. Experimental details are given elsewhere 
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In order to prepare the protein solutions, native 
alkaline phosphatase and apophosphatase were dial- 
ysed against water, then against 5 X 1 Oe3 M tris-HCl 
buffer, pH 7.5 (metal-free). In the case of the *lBr 
NMR measurements, the solutions (1 ml) contained 
about 0.5 MKBr, protein and 0.055 M tris-HCl buffer. 
Protein and KBr concentrations and pH values are 
given in table 1. In the case of the 35Cl NMR experi- 
ments, samples (2 ml) contained about 0.5 M KCI, 
protein and 0.055 M tris-HCl buffer. 
3. Results and discussion 
Fig. 1 depicts the 35Cl NMR spectra of aqueous 
KC1 solutions under various conditions. The 35C1 
NMR line width in a 0.5 M KC1 solution is very nar- 
row, about 13 Hz, due to the symmetrical solvation 
and the rapid tumbling of the chloride ion. From the 
spectrum shown in fig. 1 b it can be estimated that the 
35Cl line width in the presence of apophosphatase is 
23 Hz. This 10 Hz broadening caused by apophos- 
phatase can arise from the presence of 3% residual 
zinc, and from the weak binding of Cl- to a variety of 
side chains of the protein molecule. During the NMR 
measurements no significant change in the stability 
of the apoenzyme was observed, since Zn2+ addition 
restored enzymatic activity completely. 
The 35Cl NMR spectrum of a 0.5 M aqueous KC1 
solution exhibits a dramatic broadening when Zn2+- 
alkaline phosphatase is present in the solution. A re- 
presentative spectrum is shown in fig. 1 c. This in- 
crease in the chlorine resonance width, for compar- 
able protein concentrations, is 72 Hz for Zn2+-alkaline 
phosphatase, while only 10 Hz for the apoenzyme. 
Experiments showed that the 35Cl line broadening 
produced by Zn2+-alkaline phosphatase is orders of 
magnitude larger than that produced by Zn2+ alone 
(cf. [9]). This enhanced broadening might be the 
result of either Cl- occupying a coordination site of 
the zinc ion bound to the enzyme or of a metal-in- 
duced conformational change. 
Titration of an apoalkaline phosphatase solution 
containing 0.5 M KC1 with Zn2+, using the 35Cl NMR 
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Fig. 1. 3sC1 nuclear magnetic resonance absorption of 0.5 M 
KC1 solution. 
a) no protein, line width = 13 Hz; 
b) 1.1 X lo4 M apoalkaline phosphatase in 0.055 M tris buf- 
fer (pH 7.6), line width = 23 Hz. This experiment was per- 
formed in the presence of 0.4 M KCl; 
c) 1.1 X lo4 M Zn*+ -alkaline phosphatase (zinc/enzyme = 
4.8) in 0.055 M tris buffer (pH 7.6), line width = 85 Hz. 
This experiment was performed in the presence of 0.4 M 
KCl; 
d) 8.75 X lo-’ M Cu*+-alkaline phosphatase (copper/enzyme = 
4.2) in 0.055 M tris buffer (pH 7.0), line width = 60 Hz; 
e) 8.75 X lo-’ M Co*+ -alkaline phosphatase (cobalt/ enzyme = 
4.5) in 0.055 M tris buffer (pH 7.2), line width = 21 Hz. 
line width as the measured parameter, yields a titra- 
tion curve differing markedly from pervious experi- 
ments of this type [ l-3,7,10,29] . Thus the first ad- 
ditions of Zn2+ give no increase in line width compared 
to apophosphatase. Above a molar ratio Zn2+ to en- 
zyme about one the line width starts increasing. (The 
point where the resonance signal begins to broaden 
seems to depend on the pH used.) This may indicate 
that the first zinc equivalent is not accessible for chlo- 
ride binding. On the other hand, if the Cl‘ binding is a 
result of metal-induced conformational changes, then 
the first zinc atom does not cause such alterations. 
A further possibility is that cooperative interactions 
occur. 
As is shown by the spectrum in fig. Id, Cu2+-al- 
kaline phosphatase also has a strong line broadening 
effect on the chlorine resonance. The increase of 
the SSCl line width at 8.75 X 10-5 M protein concen- 
tration is 47 Hz. The shape of the apophosphatase 
titration curve with Cu2+ is similar to the one des- 
cribed above for Zn2’. In contrast to the Zn2+- and 
Cu2+-enzymes and to Co2+-carbonic anhydrases [29], 
no broadening due to addition of Co2+to an apoal- 
kaline phosphatase solution was detected at the ex- 
perimental conditions employed (fig. le). There are 
several possible interpretations of this fact: 1) the as- 
sociation of cobalt with the protein is not sufficiently 
strong under the experimental conditions. However, 
this possibility can be ruled out since activity measure- 
ments gave the value corresponding to Co2+-enzyme. 
Furthermore, the optical spectrum was identical with 
that of &+-alkaline phosphatase; 2) the most im- 
portant aspect is that the metal must be accessible for 
chloride binding in order to affect the chlorine reso- 
nance. Thus, it is plausible that Cd’ does not have 
available a coordination site for chloride. This is in 
accordance with the fact that addition of a Cd+ salt 
to an aqueous solution of an alkali chloride produces 
only small changes in the 35C1 magnetic relaxation 
rate. On the other hand, the addition of Cu2+ and Zn2+ 
salts substantially broadens the 35C1 magnetic reso- 
nance signal (unpublished measurements; cf. above). 
Table 1 summarizes the 81Br line width measure- 
ments made on 0.5 M KBr solutions containing apo- 
phosphatase and different metallophosphatases. As 
may be seen, the effect of apophosphatase is relatively 
smaller in this case. The Cu2+- and Cc?+-alk&ne phos- 
phatases produce, at the pH used, the same line 
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Table 1 
August 1970 
’ *Br NMR line widths for KBr solutions in the presence of apophosphatase and different metallophosphatases. 
Enzyme Protein concn. (M) KBr concn. (M) PH Line width (gauss) 
- 0.5 6.0 0.25 







1 Zn”/E 1.05 x lo4 0.5 6.0 0.34 
3 Zn2+/E 1.05 x 1o-4 0.5 6.0 0.3 1 




1.27 x 10” 
1.27 X 10” 
1.27 X lo4 
7.05 x 10-s 
7.05 x 1o-5 
7.05 x 10-s 
7.05 x 10-s 
0.5 7.8 0.32 
0.5 7.8 0.36 
0.5 7.8 0.41 




0.4 7.5 0.28 
0.4 7.5 0.31 
0.4 7.5 0.29 
2 Co’+/E 7.05 x 10-s 0.4 7.8 0.28 
5 Co2+/E 7.05 x 10-s 0.4 7.8 0.28 
pH was adjusted by 0.05 M tris-HCI buffer. Temperature 29 + 2O. E stands for enzyme. 
broadenings as the apophosphatase. Addition of Zn2+ 
ions to a 0.5 M KBr solution containing apophosphat- 
ase gives a strong line broadening at pH 7.8. At other 
pH values the effect is smaller or absent. The small ef- 
fect of apophosphatase is probably the result of bro- 
mide binding to the protein unrelated to the metallic 
sites (cf. [30]). 
Orthophosphate is a competitive inhibitor of 
E. coli alkaline phosphatase. However, it also undergoes 
a catalytic exchange reaction with H, 180 [ 22,3 I] . 
Thus, it may also be regarded as a simple phosphatase 
substrate. Titration of the Zn2+-alkaline phosphatase 
solution with K2HP04 in an 0.5 M NaCl solution was 
performed, using the 35Cl NMR line width as the mea- 
sured parameter. Addition of phosphate reduces the 
line width markedly, which implies that phosphate 
either coordinates to zinc or binds to the enzyme in 
some other way, preventing access of chloride ions. 
From the experiments reported here, we conclude 
that the halide ion probe technique offers a valuable 
method for studying several important aspects of the 
alkaline phosphatase molecule. The variation of re- 
laxation rate with the metal content of the enzyme 
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gives information of the interaction between alkaline 
phosphatase and metal ions. Furthermore, competi- 
tion between phosphate and chloride may be indicated 
by the influence of phosphate on the broadening of 
35C1 NMR line width produced by Zn2’-alkaline phos- 
phatase. Our present data do not reveal the exact af- 
finity or stoichiometry of phosphate binding to the 
enzyme. Nevertheless, this study indicates that the 
halide probe technique can be used to obtain informa- 
tion concerning enzyme-substrate interactions. 
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